Labs / CDMO: development & manufacturing

Biome Bank
Adelaide, Australia · biomebank.com
GMP
BiomeBank is a clinical-stage biotechnology company that develops microbiome therapeutics and operates an office and research facility in Adelaide, South Australia. It focuses on restoring gut microbial ecology through donor-derived and cultured microbial products for use in treating disease.
Services can be ordered directly on their website, often with listed prices. Their ordering page
What they offer
Donor-derived microbiome therapy
Develops and supplies a regulated donor-derived microbiome therapy for licensed medical practitioners in Australia.
Cultured microbiome therapeutics development
Designs next-generation co-cultured microbial therapies using its CONSORTIOME platform.
Microbiome drug development
Uses clinical and microbiome data to identify organisms and mechanisms of action for therapy development.
Clinical translation of microbiome therapies
Advances microbiome candidates through discovery, clinical trials, and registration.
What they work on
- Modalities
- Cell therapy
- Species and models
- human gut microbiome
- Assays and studies
- clinical trials, discovery trials, human trials
- Instruments and platforms
- bioreactor
- Therapeutic areas
- ulcerative colitis, recurrent Clostridioides difficile infection, inflammatory bowel disease, immunity, metabolism, neurology, oncology, Crohn’s disease
- Sites
- Adelaide, Australia
- Quality
- cGMP (manufacturing facility) · Australian regulators approval (BIOMICTRA donor-derived microbiome drug product)
- Serves
- Australia, global markets
- Founded
- 2018
Similar labs. AGC Biologics, Bambusa Therapeutics, EirGenix, enGenes
Found in a contract services directory. Listing built from biomebank.com. Work here? Claim this listing.